December 31,
2008 2007
Sales 59,057,147 22,269,492
Cost of goods sold 51,549,964 19,553,247
Gross Profit 7,507,183 2,716,245
12.7% 12.2%
Operating expenses
Selling expenses -- --
General and administrative expenses 1,035,373 885,273
Total operating expenses 1,035,373 885,273
Income from operations 6,471,810 1,830,972
11.0% 8.2%
Non-operating income (expense)
Interest expenses (31,714) (43,594)
Subsidy income 116,157 328,697
Other income (expenses) (60,901) (17,427)
Stock-based compensation - make good
provision (9,838,354) --
Total Non-operating income (expense) (9,814,812) 267,676
Net income (3,343,002) 2,098,648
-5.7% 9.4%
Other comprehensive item
Foreign currency translation gain (loss) (172,446) 1,189,031
Comprehensive income (3,515,448) 3,287,679
-6.0% 14.8%
Net income (3,343,002) 2,098,648
Deemed dividend to preferred stockholders 863,014 3,398,534
Net income available to common
stockholders (4,206,016) (1,299,886)
Basic
'/>"/>SOURCE China Bio Energy Holdings Group Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related biology technology :1.
aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong2.
Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China3.
China-Biotics, Inc. Appoints New Chief Financial Officer4.
China Medical Technologies Senior Management Purchased Company Shares5.
China Bio-Immunity Corporation - Rabies Vaccine Recall6.
China Medicine to Participate in 2009 Natural Products Expo West Trade Show7.
China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets8.
Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent9.
Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research10.
China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan11.
OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China